{"slug": "google-antigravity-enhances-drug-discovery-with-cheminformatics-skills", "title": "Google Antigravity enhances drug discovery with cheminformatics skills", "summary": "Google DeepMind's Antigravity agent platform, demonstrated on October 15, 2026, identified a new antimicrobial peptide candidate with promising activity against Streptococcus pseudopneumoniae by using the ProtNLM model to sift through millions of unannotated UniProt entries and validating the candidate in silico with AlphaFold. The platform integrates more than 30 scientific databases and builds on the Science Skills suite Google introduced in May 2026, which includes more than 11 proteomics and cheminformatics tools, compressing biological data workflows that historically took days into minutes without requiring scientists to write code. The candidate's wet-lab experimental plan is in the validation phase, so the peptide has not yet been confirmed in physical experiments.", "body_md": "# Google Antigravity enhances drug discovery with cheminformatics skills\n\nGoogle DeepMind's agent platform links more than 30 scientific databases to compress research workflows from days into minutes\n\n[Google](https://cryptobriefing.com/markets/alphabet/) DeepMind wants AI agents to do more than write code and summarize emails. Its Antigravity platform is now being pointed at drug discovery, where a single bad lead can burn months of lab time.\n\nIn an October 15, 2026 technical demonstration, the platform helped identify a new antimicrobial peptide candidate.\n\n## From millions of entries to one candidate\n\nThe demo centered on antimicrobial peptides, short chains of amino acids that can fight bacteria. Researchers used DeepMind’s ProtNLM model to sift through millions of unannotated UniProt entries.\n\nUniProt is a large public protein database. “Unannotated” means many of those entries have no known function attached.\n\nOut of that pile, the workflow surfaced a new peptide candidate. It shows promising activity against respiratory pathogens, specifically *Streptococcus pseudopneumoniae*.\n\nThe candidate was then checked in silico using AlphaFold, DeepMind’s protein structure prediction model. In silico simply means the testing happened on a computer rather than in a petri dish.\n\nThe process ended with a wet-lab experimental plan. That plan is currently in the validation phase, so the peptide has not yet proven itself in physical experiments.\n\n### AI, tech, and the markets they move—in one daily briefing.\n\nDaily. Free. Join 34,000+ readers across crypto, finance, and policy.\n\n## What Antigravity actually does\n\nAt its core, Antigravity is a platform for AI agents working on life-science research. It integrates more than 30 scientific databases alongside DeepMind’s own models.\n\nThe pitch is speed. Exploring and analyzing biological data has historically taken days, according to the research findings. With Antigravity, researchers can expect to finish complex workflows in a matter of minutes.\n\nThe outputs are meant to be more than rough notes. The platform produces artifacts described as ready for publication, including 3D renderings and experimental plans.\n\nNotably, scientists can generate those outputs without writing code.\n\n## Building on Science Skills\n\nAntigravity did not appear from nowhere. It builds on the Science Skills suite, which Google introduced in May 2026.\n\nScience Skills includes more than 11 tools covering proteomics and cheminformatics. Proteomics is the large-scale study of proteins, which makes it a natural partner for a peptide-hunting demo.\n\nThe suite aimed to streamline AI-assisted drug discovery across the biotech sector. Antigravity takes those tools and wraps them in an agent layer that can chain steps together on its own.\n\nGoogle Cloud has also detailed a three-layer AI infrastructure built specifically for biotech drug discovery tasks.\n\n**Disclosure:** This article was edited by Diego Almada Lopez. For more information on how we create and review content, see our [Editorial Policy](https://cryptobriefing.com/editorial-policy/).\n\n## More in AI\n\n[See all](https://cryptobriefing.com/artificial-intelligence/)", "url": "https://wpnews.pro/news/google-antigravity-enhances-drug-discovery-with-cheminformatics-skills", "canonical_source": "https://cryptobriefing.com/google-antigravity-drug-discovery-cheminformatics/", "published_at": "2026-11-03 17:05:43+00:00", "updated_at": "2026-11-03 18:22:56.876862+00:00", "lang": "en", "topics": ["artificial-intelligence", "ai-agents", "ai-research", "ai-tools"], "entities": ["Google DeepMind", "Antigravity", "ProtNLM", "UniProt", "AlphaFold", "Science Skills", "Google Cloud", "Streptococcus pseudopneumoniae"], "also_reported_by": [{"url": "https://explainx.ai/blog/deepmind-antigravity-cheminformatics-skills-rdkit-lorlatinib-macrocycle-2026?utm_source=rss&utm_medium=feed&utm_campaign=blog", "source": "explainx.ai", "title": "DeepMind Gives Antigravity Cheminformatics Skills: An Agent Designs Lorlatinib-Style Macrocycles in an Hour", "published_at": "2026-11-03T00:00:00+00:00"}], "alternates": {"html": "https://wpnews.pro/news/google-antigravity-enhances-drug-discovery-with-cheminformatics-skills", "markdown": "https://wpnews.pro/news/google-antigravity-enhances-drug-discovery-with-cheminformatics-skills.md", "text": "https://wpnews.pro/news/google-antigravity-enhances-drug-discovery-with-cheminformatics-skills.txt", "jsonld": "https://wpnews.pro/news/google-antigravity-enhances-drug-discovery-with-cheminformatics-skills.jsonld"}}